Albion Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Albion Financial Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.44K	Hold	58	–	–	﹤0.01%	533
2026 Q1	$1.53K	Hold	58	–	–	﹤0.01%	595
2025 Q4	$1.68K	Hold	58	–	–	﹤0.01%	555
2025 Q3	$1.61K	Sell	58 -80	-58%	-$2.02K	﹤0.01%	545
2025 Q2	$3.36K	Hold	138	–	–	﹤0.01%	440
2025 Q1	$2.87K	Buy	138 +82	+146%	+$2.06K	﹤0.01%	459
2024 Q4	$1.32K	Sell	56 -477	-89%	-$11.7K	﹤0.01%	590
2024 Q3	$13.6K	Hold	533	–	–	﹤0.01%	315
2024 Q2	$12.5K	Hold	533	–	–	﹤0.01%	317
2024 Q1	$15.3K	Hold	533	–	–	﹤0.01%	295
2023 Q4	$17.5K	Hold	533	–	–	﹤0.01%	279
2023 Q3	$14.9K	Hold	533	–	–	﹤0.01%	274
2023 Q2	$18.2K	Hold	533	–	–	﹤0.01%	276
2023 Q1	$16K	Hold	533	–	–	﹤0.01%	276
2022 Q4	$15K	Hold	533	–	–	﹤0.01%	274
2022 Q3	$18K	Hold	533	–	–	﹤0.01%	265
2022 Q2	$17K	Hold	533	–	–	﹤0.01%	280
2022 Q1	$24K	Buy	533 +11	+2%	+$524	﹤0.01%	300
2021 Q4	$32K	Buy	522 +41	+9%	+$2.83K	﹤0.01%	315
2021 Q3	$36K	Sell	481 -19	-4%	-$1.59K	﹤0.01%	277
2021 Q2	$46K	Buy	+500	New	+$42.5K	﹤0.01%	260
2020 Q4	$0	Buy	+1	New	+$80	﹤0.01%	485

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Albion Financial Group's ARKG Position: Q2 2026 in Review

Albion Financial Group held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 58 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #533.

Albion Financial Group first reported a position in ARKG in Q4 2020 and has held it in 22 quarters since. The position peaked at $46K in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Albion Financial Group held 58 shares of ARK Genomic Revolution ETF worth $2.44K as of Q2 2026.
Albion Financial Group left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #533 holding.
Albion Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 22 quarters since.
Albion Financial Group's ARK Genomic Revolution ETF position peaked at $46K in Q2 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.